StockData
DaVita Inc. logo

DaVita Inc. (DVA) stock

DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3041% below fair value
$183.50+4.22 (+2.35%)

Close on Nov 11, 2026Market cap $11.54BP/E 13.5Yield –

DaVita Inc. grew revenue 6.4% to $14.17B over the twelve months to Sep 30, 2026. Operating income rose 3.6% to $2.12B, moving the operating margin from 15.4% to 15.0%. Free cash flow was $1.29B, up 0.1% from a year earlier. At the latest close the market valued the company at $11.54B, 13.5 times its earnings.

Revenue
$14.17B
+6.4% vs. a year earlier
Operating income
$2.12B
+3.6% vs. a year earlier
Free cash flow
$1.29B
+0.1% vs. a year earlier
EPS, diluted
$13.58
+39.9% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$11.54B
P/E ratio
13.5
Price to sales
0.81
Price to book
–
Dividend yield
–
Free cash flow yield
11.21%

Fundamentals

Revenue
$14.17B
Net income
$920.08M
EPS, diluted
$13.58
Free cash flow
$1.29B
Book value per share
-$9.02
Diluted shares
66M

Trading

Next earnings
Feb 1, 2027 (estimated, during market hours)
Previous close
$179.28
Open
$177.09
Day's range
$177.09 – $183.50
Volume
573,328
Average volume (20 days)
897,695
Index membership
S&P 500, Russell 1000, Russell 3000
Beta (5 years)
0.37
52-week range
$101.00 – $247.49
RSI (14 days)
48.8
Volatility (1 year)
46.9%
Relative volume
0.73×
WACC
6.4%

On 1 of our idea list: Buyback cannibals

Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2009, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodDVAS&P 500DifferenceDVA per yearS&P 500 per year
1 month+2.4%-2.4%+4.8 pts
3 months+2.9%-1.2%+4.0 pts
Year to date+61.5%+12.3%+49.2 pts
1 year+50.1%+12.4%+37.6 pts
3 years+121.1%+78.8%+42.3 pts+30.3%+21.4%
5 years+72.9%+75.2%−2.3 pts+11.6%+11.9%
10 years+208.2%+311.1%−102.9 pts+11.9%+15.2%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$14.17B+6.4% YoY

Operating income

$2.12B+3.6% YoY

Net income

$920.08M+19.2% YoY

EPS, diluted

$13.58+39.9% YoY

Free cash flow

$1.29B+0.1% YoY
Reported periodTrailing twelve months

Press releases

Releases DaVita filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About DaVita

Services-Misc Health & Allied Services, NEC

DaVita Inc. provides comprehensive kidney care services to individuals suffering from chronic kidney disease and end-stage kidney disease. Its core operations encompass outpatient hemodialysis, hospital inpatient hemodialysis, home-based peritoneal and hemodialysis support, and specialized clinical laboratory testing. Beyond direct dialysis treatments, the company delivers integrated kidney care programs coordinating patient management across the disease continuum, clinical research services, and transplant management software. Its customers primarily include kidney disease patients, commercial health plans, hospitals, and government healthcare programs such as Medicare and Medicaid.

Company profile, executives and history

DaVita stock: common questions

What is DaVita's stock price?

DVA closed at $183.50 on Nov 11, 2026, up 2.35% on the day. Over the past 52 weeks it traded between $101.00 and $247.49.

What is DaVita's market cap?

DaVita was worth $11.54B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is DVA's P/E ratio?

DVA trades at 13.5 times earnings, based on diluted earnings per share of $13.58 over the twelve months to Sep 30, 2026.

How much revenue does DaVita make?

DaVita reported revenue of $14.17B for the twelve months to Sep 30, 2026, up 6.4% from a year earlier.

Does DaVita pay a dividend?

No. DaVita has not paid a cash dividend over the last twelve months.

When does DaVita report earnings next?

DaVita is expected to report Q4 FY2026 results on Feb 1, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has DVA stock performed over the past year?

Including dividends, DVA returned +50.1% over the past year, against +12.4% for the S&P 500.

How many DVA shares are sold short?

5M shares were sold short at the latest FINRA report, 20.04% of the float, or 5.1 days of average trading volume.

Who are DaVita's competitors?

Companies most similar to DaVita by business, industry and size include AGL, BTSG, THC, CYH, LH.

See a number that looks wrong?